Publications | PubMed=978138; DOI=10.1084/jem.144.4.873; PMCID=PMC2190439 Hiroshi Shiku, Toshitada Takahashi, Herbert Friedrich Oettgen, Lloyd John Old; Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J. Exp. Med. 144:873-881(1976) PubMed=1067619; DOI=10.1073/pnas.73.9.3278; PMCID=PMC431008 Thomas E. Carey, Toshitada Takahashi, Lois A. Resnick-Silverman, Herbert Friedrich Oettgen, Lloyd John Old; Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc. Natl. Acad. Sci. U.S.A. 73:3278-3282(1976) PubMed=327080; DOI=10.1093/jnci/59.1.221 Jorgen Fogh, Jens M. Fogh, Thomas Orfeo; One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59:221-226(1977) PubMed=833871; DOI=10.1093/jnci/58.2.209 Jorgen Fogh, William C. Wright, James D. Loveless; Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58:209-214(1977) DOI=10.1007/978-1-4615-7228-2_39 Alan N. Houghton, Herbert Friedrich Oettgen, Lloyd John Old; Malignant melanoma. Current status of the search for melanoma-specific antigens. (In book chapter) Immunodermatology. Comprehensive Immunology, Vol 7; Safai, Bijan & Good, Robert Alan (eds.); pp.557-576; Springer; Boston; USA (1981) PubMed=3518877; DOI=10.3109/07357908609038260 Jorgen Fogh; Human tumor lines for cancer research. Cancer Invest. 4:157-184(1986) PubMed=22970293; DOI=10.1371/journal.pone.0044707; PMCID=PMC3435279 Rona Y. Zhao, Nicole A. Mifsud, Kun Xiao, Kok-Fei Chan, Sara Oveissi, Heather M. Jackson, Nektaria Dimopoulos, Philippe Guillaume, Ashley J. Knights, Tamara Lowen, Neil C. Robson ...Show all 18 authors... , Sarah E. Russell, Emmanuel Scotet, Ian D. Davis, Eugene Maraskovsky, Jonathan S. Cebon, Immanuel F. Luescher, Wei-San Chen; Show fewer authors A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen. PLoS ONE 7:e44707.1-e44707.12(2012) |